Skip to main content
  • Advertise
    Want to Advertise with Us?
    Conquer welcomes advertising and sponsorship collaborations with reputable companies offering high-quality products and services to people affected by cancer.
  • Affiliated Brands
    Academy of Oncology Nurse & Patient Navigators
    The Academy of Oncology Nurse & Patient Navigators (AONN+) is the largest national specialty organization dedicated to improving patient care and quality of life by defining, enhancing, and promoting the role of oncology nurse and patient navigators. Our organization of over 8,900 members was founded in May 2009 to provide a network for all professionals involved and interested in patient navigation and survivorship care services to better manage the complexities of the cancer care treatment continuum for their patients. We view our organization as one consisting of “professional patient advocates” and, to that end, we support and serve our members.
    Journal of Oncology Navigation & Survivorship
    The Journal of Oncology Navigation & Survivorship (JONS) promotes reliance on evidence-based practices in navigating patients with cancer and their caregivers through diagnosis, treatment, and survivorship. JONS also seeks to strengthen the role of nurse and patient navigators in cancer care by serving as a platform for these professionals to disseminate original research findings, exchange best practices, and find support for their growing community.
    The Oncology Nurse-APN/PA
    The Oncology Nurse-APN/PA (TON) provides coverage of the wide spectrum of oncology-related events, trends, news, therapeutics, diagnostics, organizations, and legislation that directly affect hematology/oncology nurses and advanced practitioners involved in healthcare delivery and product utilization. The scope and coverage include a unique presentation of news and events that are shaping the care of patients with cancer.
  • Healthcare Providers
  • Contribute

Stem-Cell Transplantation in Mantle-Cell Lymphoma

Web Exclusives

The choice of treatment for mantle-cell lymphoma depends on several factors, including the stage of disease, the age of the patient, and the patient’s overall health. Overall health is important, because some patients require more gentler treatments than others.1,2

High-dose chemotherapy is often used to kill cancerous white blood cells in patients with lymphoma (including mantle-cell lymphoma). Unfortunately, chemotherapy also kills some of the stem cells the body needs to replace the cancerous cells with new, healthy cells. A stem-cell transplant replaces the stem cells that were destroyed and restores the ability of the bone marrow to make new blood cells.1,3

Because the combination of high-dose chemotherapy and stem-cell transplant places great strain on the body, this approach may not be an option for every patient. Fit patients are usually better able to tolerate the treatment, which may keep mantle-cell lymphoma under control for a longer period of time.1,4 Patients and their loved ones have many factors to consider when deciding whether a stem-cell transplant is an appropriate treatment for them.

In mantle-cell lymphoma, eligible patients receive an autologous stem-cell transplant, which means their own blood-forming stem cells are collected. The collection process, during which blood is drawn from a vein, may take from 1 to 5 days. The blood is then put through an apheresis machine, which separates the stem cells from the other blood cells.3

Autologous stem-cell transplantation is most commonly recommended when patients have aggressive mantle-cell lymphoma that responds to chemotherapy. The treatment usually requires a hospital stay with a long recovery process, which comes with a number of side effects. Although most of these side effects are temporary—such as low blood cell counts, infection, fatigue, and hair loss—stem-cell transplants may also result in infertility.3

It is important for patients to discuss all possible therapeutic options—including their risks and possible side effects—with their healthcare team to determine whether a stem-cell transplant is the right option.

References

  1. Lymphoma Research Foundation. Understanding the Stem Cell Transplantation Process. July 2016. www.lymphoma.org/wp-content/uploads/2017/06/STEM_CELL_TRANSPLANTATION_BOOKLET-1.pdf. Accessed May 19, 2019.
  2. Lymphoma Action. Mantle cell lymphoma. https://lymphoma-action.org.uk/types-lymphoma-non-hodgkin-lymphoma/mantle-cell-lymphoma. Accessed May 19, 2019.
  3. Memorial Sloan Kettering Cancer Center. Autologous Stem Cell Transplant: A Guide for Patients & Caregivers. www.mskcc.org/cancer-care/patient-education/autologous-stem-cell-transplant-guide-patients-caregivers. Accessed May 19, 2019.
  4. Helwick C. Mantle cell lymphoma: Is transplantation still necessary? The ASCO Post. September 25, 2015. www.ascopost.com/issues/september-25-2015/mantle-cell-lymphoma-is-transplantation-still-necessary. Accessed May 19, 2019.

Recommended For You